Precision De Novo Biologics, Engineered In Silico

An extension of your discovery team—delivering high-affinity miniproteins, VHH nanobodies, paired Fvs, and cyclic peptides tailored to your target epitope.

Initiate a Feasibility Assessment

End-to-End Generative Design Architecture

Built by tool-builders for therapeutic discovery—combining epitope mapping, generative backbone scaffolding, and multi-parameter developability filtering.

1. Epitope & Hotspot Discovery

Structural surface analysis to identify druggable patches, cryptic pockets, and functional binding interfaces.

2. Generative Backbone & Loop Design

De novo scaffold and CDR loop construction tailored to exact steric and electrostatic complementarity.

3. Sequence & Developability Filtering

In silico folding validation, immunogenicity reduction, and solubility/stability ranking prior to wet-lab synthesis.

Biologic Design Services

Select a modality below to scope custom computational binder generation for your target.

De Novo Miniproteins

High-stability, ultra-compact binders (40–70 aa)

Structure-guided backbone generation and sequence optimization for hyper-stable scaffolds resistant to thermal and proteolytic degradation.

  • Epitope hotspot mapping
  • 100+ ranked designs (FASTA & PDB)
  • In silico folding & interface metrics

Nanobodies (VHH)

Single-domain camelid-derived binders

Generative CDR1/2/3 loop design and framework humanization tailored for cryptic epitopes, high solubility, and modular multispecific formatting.

  • CDR-grafted & de novo VHH libraries
  • Humanization & immunogenicity screening
  • Developability & aggregation filtering

Paired Antibodies (VH+VL / Fv)

Full variable-domain therapeutic candidates

Co-optimized heavy and light chain interface design targeting specific functional epitopes with high affinity and mammalian expression readiness.

  • Paired VH/VL paratope optimization
  • Epitope-specific structural complexes
  • Liability motif removal (deamidation/oxidation)

Cyclic Peptides

Constrained macrocycles for intracellular & PPI targets

Disulfide- and head-to-tail cyclized peptide design engineered to disrupt challenging protein-protein interactions with enhanced membrane permeability.

  • Backbone cyclization geometry optimization
  • Non-canonical amino acid integration
  • Binding free-energy ranking

Scope Your Custom Design Campaign

Partner with our structural biology team to define target criteria and deliverables.

IP & Confidentiality: No proprietary sequence data is required for initial scoping. Mutual CDA/NDA execution is available prior to target disclosure.